• Bardet wants Froome asthma case resolved before July• Frenchman says ‘cycling would make no sense’ if Froome rides onThe third finisher in the 2017 Tour de France, Romain Bardet, has said that if Chris Froome’s adverse analytical finding for the anti-asthma drug salbutamol dating back to last September, is not resolved before this year’s race such a situation would be a “catastrophe” for the event and for cycling.“There would be derision. It would be a farce,” Bardet told the newspaper l’Equipe. “How can our sport be credible if the No 1 rider were to race the Tour with the possibility of a retrospective sanction? Cycling would make no sense.” Related: Chris Froome fights to save career after failed drugs test result Continue readingreadfullarticle
